Advertisement

Physalaemin-Like Immunoreactivity from Human Lung Small Cell Carcinoma: Isocratic Reversed-Phase HPLC Analysis of the Chemically Modified Peptide

  • L. H. Lazarus
  • O. Hernandez
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 99)

Abstract

The metastatic human lung tumor, small cell carcinoma (SCC), exhibits ectopic (inappropriate) synthesis of numerous peptide hormones, such as ACTH, [Arg8]-vasopressin, hCGβ, calcitonin, oxytocin, prolactin, and growth hormone (Rees et al. 1974; Rees 1976; Baylin and Mendelsohn 1980). Furthermore, tumors resected from patients (Wood et al. 1981), or passaged in nude (athymic) mice (Erisman et al. 1982), or cultured into numerous cell lines (Moody et al. 1981, 1983 a, b; Sorenson et al. 1982) were found to contain immunoreactivity to the amphibian peptide bombesin and more recently to physalaemin (Erisman et al. 1982; Lazarus et al. 1983), which is the prototype of the tachykinin family of peptides discovered by Erspamer et al. (1964). The presence of immunoreactivity to bombesin was detected in human fetal and neonatal lungs (Wharton et al. 1978) and in the lungs of children (Cutz et al. 1981; Track and Cutz 1982) and appears to be associated with a mammalian form of bombesin similar to porcine gastrin-releasing peptide, a 27 amino acid residue peptide (Iwanago 1983; Price et al. 1983; Tsutsumi et al. 1983). On the other hand, the physalaemin-like immunoreactive material (PLIM), initially discovered in the gastrointestinal tract (Lazarus and DiAugustine 1980; Lazarus et al. 1980), was also present in neuronal (Lazarus et al. 1980) and pulmonary tissue from diverse mammlian species (Lazarus et al. 1982). Further studies showed however, that PLIM differed from the amphibian peptide (Lazarus et al. 1982) and the purified immunoreactive material was in fact an octapeptide with homology to the N-terminal region of physalaemin (Wilson et al. 1984).

Keywords

Small Cell Carcinoma Methionine Sulfoxide Amphibian Skin Reductive Alkylation Tumor Peptide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baylin SB, Mendelsohn G (1980) Ectopic (inappropriate) hormone production by tumors: mechanisms involved and the biological and clinical implications. Endocrin Rev 1: 45–77.CrossRefGoogle Scholar
  2. Bennett HPJ, Browne CA, Solomon S (1981) The use of perfluorinated carboxylic acids in the re-versed-phase HPLC of peptides. J Liquid Chromatogr 3: 1353–1365.Google Scholar
  3. Bertaccini G (1976) Active polypeptides of nonmammalian origin. Pharmacol Rev 28: 127–177.PubMedGoogle Scholar
  4. Bertaccini G (1980) Peptides of the amphibian skin active on the gut. I. Tachykinins (substance P-like peptides) and ceruleins. Isolation, structure, and basic functions. In: Glass GBJ (ed) Gastrointestinal hormones. Raven, New York, pp 317–340.Google Scholar
  5. Cutz E, Chan W, Track NM (1981) Bombesin, calcitonin and leu-enkephalin immunoreactivity in endocrine cells of human lung. Experientia 37: 765–767.PubMedCrossRefGoogle Scholar
  6. Erisman MD, Linnoila RI, Hernandez O, DiAugustine RP, Lazarus LH (1982) Human lung small-cell carcinoma contains bombesin. Proc Natl Acad Sci USA 79: 2379–2383.PubMedCrossRefGoogle Scholar
  7. Erspamer V (1983) Amphibian skin peptides in mammals — looking ahead. Trends Neurosci 6: 200–201.CrossRefGoogle Scholar
  8. Erspamer V, Melchiorri P (1973) Active polypeptides of the amphibian skin and their synthetic analogues. Pure Appl Chem 35: 463–494.CrossRefGoogle Scholar
  9. Erspamer V, Anastasi A, Bertaccini G, Cei JM (1964) Structure and pharmacological actions of physalaemin, the main active polypeptide of the skin of Physalaemus fuscumaculatus. Experientia 20: 489–490.CrossRefGoogle Scholar
  10. Hernandez H, Dermott K, Lazarus LH (1984) High-performance liquid chromatography of amphibian peptides. Selectivity changes induced by pH. J Liquid Chromatogr 7: 893–905.CrossRefGoogle Scholar
  11. Iwanaga T (1983) Gastrin-releasing peptide (GRP)/bombesin-like immunoreactivity in the neurons and paraneurons of the gut and lung. Biomed Res 4: 93–104.Google Scholar
  12. Kangawa K, Minamoto N, Fukuda A, Matsuo H (1983) Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord. Biochem Biophys Res Commun 114: 533–540.PubMedCrossRefGoogle Scholar
  13. Kimura S, Okada M, Sugita Y, Kanazawa I, Munekata E (1983) Novel neuropeptides, neurokinin α and β, isolated from porcine spinal cord. Proc Jpn Acad [B] 59: 101–104.CrossRefGoogle Scholar
  14. Klickstein LB, Wintroub BU (1982) Separation of angiotensins and assay of angiotensin-generating enzymes by high-performance liquid chromatography. Anal Biochem 120: 146–150.PubMedCrossRefGoogle Scholar
  15. Lazarus LH, DiAugustine RP (1980) Radioimmunoassay for the tachykinin peptide physalaemin: Detection of a physalaemin-like substance in rabbit stomach. Anal Biochem 197: 350–357.CrossRefGoogle Scholar
  16. Lazarus LH, Perrin MH, Brown MR (1977) Mast cell binding of neurotensin: I. Iodination of neurotensin and characterization of the interaction of neurotensin with mast cell receptor sites. J Biol Chem 252: 7174–7179.PubMedGoogle Scholar
  17. Lazarus LH, Linnoila RI, Hernandez O, DiAugustine RP (1980) A neuropeptide in mammalian tissues with physalaemin-like immunoreactivity. Nature 287: 555–558.PubMedCrossRefGoogle Scholar
  18. Lazarus LH, DiAugustine RP, Soldato CM (1982) A substance with immunoreactivity to the peptide physalaemin in mammalian respiratory tissue. Exp Lung Res 3: 329–341.PubMedCrossRefGoogle Scholar
  19. Lazarus LH, DiAugustine RP, Jahnke GD, Hernandez O (1983) Physalaemin: An amphibian tachykinin in human lung small-cell carcinoma. Science 219: 79–81.PubMedCrossRefGoogle Scholar
  20. Means GE, Feeney RE (1968) Reductive alkylations of amino groups in proteins. Biochem 7: 2192–2201.CrossRefGoogle Scholar
  21. Meek JL (1980) Prediction of peptide retention times in high-pressure liquid chromatography on the basis of amino acid composition. Proc Natl Acad Sci USA 77: 1632–1636.PubMedCrossRefGoogle Scholar
  22. Molnár I, Harváth C (1977) Separation of amino acids and peptides on nonpolar stationary phases by high-performance liquid chromatography. J Chromatogr 142: 623–640.PubMedCrossRefGoogle Scholar
  23. Moody TW, Pert CB, Gazdar AF, Carney DN, Minna JD (1981) High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science 214: 1246–1248.PubMedCrossRefGoogle Scholar
  24. Moody TW, Bertness V, Carney DN (1983 a) Bombesin-like peptides and receptors in human tumor cells lines. Peptides 4: 683–686.PubMedCrossRefGoogle Scholar
  25. Moody TW, Russell EK, O’Donohue TL, Linden CD, Gazdar AF (1983b) Bombesin-like peptides in small cell lung cancer: Biochemical characterization and secretion from a cell line. Life Sci 32: 487–493.PubMedCrossRefGoogle Scholar
  26. Mutt V (1983) New approaches to the identification and isolation of hormonal polypeptides. Trends Neurosci 6: 357–360.CrossRefGoogle Scholar
  27. Nawa H, Hirose T, Takashima H, Inayama S, Nakanishi S (1983) Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor. Nature 306: 32–36.PubMedCrossRefGoogle Scholar
  28. Nawa H, Doteuchi M, Igano K, Inouye K, Nakanishi S (1984) Substance K: A novel mammalian tachykinin that differs from substance P in its pharmacological profile. Life Sci 34: 1153–1160.PubMedCrossRefGoogle Scholar
  29. Price J, Penman E, Bourne GL, Rees LH (1983) Characterization of bombesin-like immunoreactivity in human fetal lung. Regul Pept 7: 315–322.PubMedCrossRefGoogle Scholar
  30. Rees LH (1976) Concepts in ectopic hormone production. Clin Endocrinol [Suppl] 5: 363s–372s.CrossRefGoogle Scholar
  31. Rees LH, Bloomfield GA, Rees GM, Corrin B, Franks LM, Ratcliffe JG (1974) Multiple hormones in a bronchial tumor. J Clin Endocrinol Metab 3: 1090–1097.CrossRefGoogle Scholar
  32. Sorenson GD, Bloom SR, Ghatei MA, Del Prete SA, Cate CA, Pettengill OS (1982) Bombesin production by human small cell carcinoma of the lung. Regul Pept 4: 59–66.PubMedCrossRefGoogle Scholar
  33. Track NS, Cutz E (1982) Bombesin-like immunoreactivity in developing human lung. Life Sci 30: 1553–1556.PubMedCrossRefGoogle Scholar
  34. Tsutsumi Y, Osamura RY, Watanabe K, Yanaihara N (1983) Simultaneous immunohistochemical localization of gastrin-releasing peptide (GRP) and calcitonin (CT) in human bronchial endocrine-type cells. Virchows Arch [A] 400: 163–171.CrossRefGoogle Scholar
  35. Wharton J, Polak JM, Bloom SR, Ghatei MA, Solcia E, Brown MR (1978) Bombesin-like immunoreactivity in the lung. Nature 273: 769–771.PubMedCrossRefGoogle Scholar
  36. Wilson WE, Harvan DJ, Hamm C, Lazarus LH, Klapper DG, Yajima H (1985) Physalaemin-like peptides: purification and elucidation of structure using atom bombardment-tandem mass spectrometry. In: Proceedings of the Ninth American Peptide Symposium. Pierce Chemical, Rockford.Google Scholar
  37. Wood SM, Wood JR, Ghatei MA, Lee YC, O’Shaughnessy D, Bloom SR (1981) Bombesin, somatostatin and neurotensin-like immunoreactivity in bronchial carcinoma. J Clin Endocrinol Metab 53: 1310–1312.PubMedCrossRefGoogle Scholar
  38. Yasuhara T, Nakajima T, Nokihara K, Yanaihara C, Yanaihara N, Erspamer V, Erspamer GF (1983) Two new frog skin peptides, phyllolitorins, of the bombesin-ranatensin family from Phyllomedusa sauvagei. Biomed Res 4: 407–412.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • L. H. Lazarus
    • 1
  • O. Hernandez
    • 1
  1. 1.Laboratory of Behavioral and Neurological Toxicology, Bio-organic Chemistry Laboratory of Molecular BiophysicsNational Institute of Environmental Health SciencesResearch Triangle ParkUSA

Personalised recommendations